Characteristics of patients with dyslipidemia treated in routine care setting in China

Figures & data

Table 1. Patient demographics and dyslipidemia at diagnosis.

	With diabetes				Without diabetes
	All	With ASCVD	Without ASCVD		All	With ASCVD	Without ASCVD
Characteristic	n = 852	n = 279	n = 573	p-Value	n = 1018	n = 323	n = 695	p-Value
Age (years) [mean (SD)]	63.8 (10.4)	67.4 (9.6)	62.2 (10.3)	<.0001	61.6 (11.5)	66.1 (10.3)	59.5 (11.4)	<.0001
Male (%)	57	59	56	.34	59	63	57	.06
Employment status (%)
Working full time	19	11	23	<.0001	28	16	33	<.0001
Working part time	1	1	2	.76	2	3	2	.33
Homemaker	6	4	7	.81	7	5	8	.18
Student	0	0	0	NA	<1	0	<1	1
Retired	72	83	66	<.0001	62	74	56	<.0001
Unemployed	2	2	2	.80	1	2	1	.56
Has caregiver (%)	21	34	14	<.0001	15	29	9	<.0001
Time since diagnosis (years) [mean (SD)]	2.4 (2.7)	3.4 (3.5)	2.0 (2.1)	<.0001	1.9 (2.5)	2.6 (2.8)	1.6 (2.3)	<.0001
LDL-C at diagnosis (mg/dL) [mean (SD)]	168.9 (33.0)	172.4 (33.8)	167.4 (32.6)	.07	168.4 (34.86)	171.7 (37.1)	167.1 (33.9)	.08
Statin use	88	94	85	.002	89	95	86	<.0001

ASCVD atherosclerotic cardiovascular disease; NA, not applicable.

Figure 1. Hyperlipidemia diagnoses among patients stratified by diabetes and ASCVD status. ASCVD, atherosclerotic cardiovascular disease. Combined hyperlipidemia: hyperlipidemia/hypertriglyeridemia

Table 2. Patient comorbidities.

	With diabetes				Without diabetes
	All	With ASCVD	Without ASCVD		All	With ASCVD	Without ASCVD
Characteristic	n = 852	n = 279	n = 573	p-Value	n = 1018	n = 323	n = 695	p-Value
Number of comorbidities [mean (SD)]^a	3.0 (1.9)	4.4 (2.1)	2.2 (1.3)	<.0001	2.8 (1.6)	4.1 (1.5)	2.2 (1.3)	<.0001
Comorbidities (%) (≥15% frequency in any group)
Hypertension	74	81	70	.0004	77	80	76	.3
Atherosclerosis	37	59	26	<.0001	33	54	23	<.0001
Coronary heart/artery disease	34	56	23	<.0001	38	62	27	<.0001
Unstable angina	13	36	2	<.0001	15	42	3	<.0001
Peripheral vascular disease	7	20	0	<.0001	3	9	0	<.0001
Myocardial infarction	7	18	2	<.0001	6	14	2	<.0001
Stable angina	5	15	0	<.0001	5	16	0	<.0001
Comorbidities of special interest (%)
Retinopathy	6	10	4	.0007	1	1	1	.77
Neuropathy	3	6	2	.0009	1	2	1	.15

ASCVD, atherosclerotic cardiovascular disease. ^aExcluding diabetes mellitus and dyslipidemia.

Figure 2. Self-reported adherence¹ to lipid-lowering therapies, stratified by diabetes and ASCVD status.

Data availability statement

The data that support the findings of this study are not publicly available due to contractual restrictions regarding their use.